Skip to main content

Global Bio Decontamination Market Size to Reach USD 280.8 Million 2030 | Emergen Research

Rising prevalence of hospital-acquired infections is a significant factor driving the global bio decontamination market revenue growth

Vancouver, Aug. 29, 2023 (GLOBE NEWSWIRE) — The latest analysis conducted by Emergen Research forecasts that the global bio decontamination market will attain a size of approximately USD 280.8 Million by the year 2030, exhibiting a consistent compound annual growth rate (CAGR) of 7.3% in terms of revenue. One of the key factors propelling the upward trajectory of market revenue is the escalating incidence of hospital-acquired infections. Annually, the European Centre for Disease Prevention (ECDC) approximates that between 3.1 million to 4.6 million individuals within the European Union (EU), Iceland, Norway, and the U.K. acquire a Hospital Acquired Infection (HAI). These infections obtained during hospital stays hold the potential to substantially amplify patient morbidity, mortality rates, and expenses linked to healthcare provision. Within the same geographical regions, the six most prevalent healthcare-associated ailments culminate in over 90,000 fatalities each year. Among these adversities, HAIs stand out as the most severe and financially burdensome, constituting a share of up to 6% in the budget allocations of public hospitals.

The surging prevalence of HAIs stands as a catalyst driving the demand for bio decontamination services, thereby making a significant contribution to the growth in market revenue. Novel no-touch (automatic) decontamination techniques encompass a range of advanced approaches, including aerosol and vaporized hydrogen peroxide, portable devices emitting continuous Ultraviolet C (UVC) light, pulsed-xenon UV light systems, and the application of high-intensity narrow-spectrum (405 nm) light. These innovative methods have demonstrated efficacy in minimizing bacterial contamination on surfaces. Another avenue gaining attention involves rendering surfaces self-disinfecting through the application of heavy metals like silver or copper, possessing inherent antimicrobial properties, or utilizing compounds that sustain antimicrobial activity over extended durations. These strategies hold promise for curbing microbial presence on hospital surfaces.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1460

Nevertheless, healthcare practitioners routinely confront the challenge of delivering swift outcomes within limited budgetary constraints. Clients demand solutions that are not only prompt and cost-effective but also judicious in resource utilization. It’s imperative that the chosen bio-decontamination method not only avoids detrimental effects on valuable equipment and the workspace but also maintains a reasonable service cost. These considerations bear the potential to impede the progression of market revenue growth.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1460

Scope of Research

Report Details Outcome
Market size in 2021 USD 147.7 Million
CAGR (2022-2030) 7.3%
Revenue forecast to 2030 USD 280.8 Million
Base year for estimation 2021
Historical data 2021-2030
Forecast period 2022-2030
Quantitative units Revenue in USD Million and CAGR in % from 2022 to 2030
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Product & service, agent type, type, end-use, and region
Regional scope North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Country scope U.S., Canada, Mexico, Germany, U.K., France, Spain, BENELUX, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, U.A.E., Israel, and Rest of MEA
Key companies profiled STERIS, Ecolab, TOMI Environmental Solutions, Inc., Fedegari Autoclavi S.p.A., Zhejiang TAILIN Bioengineering Co., LTD, Howorth Air Technology Limited, Solidfog Technologies, ClorDiSys Solutions Inc., Amira Srl Unipersonale, and Noxilizer, Inc.
Customization scope 10 hours of free customization and expert consultation

Major Companies and Competitive Landscape

The global bio decontamination market is partially fragmented, with several large and medium-sized players accounting for the majority of market revenue. Major companies are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective bio decontamination services. Some major players included in the global bio decontamination market report are:

  • STERIS
  • Ecolab
  • TOMI Environmental Solutions, Inc.
  • Fedegari Autoclavi S.p.A.
  • Zhejiang TAILIN Bioengineering Co., LTD
  • Howorth Air Technology Limited
  • Solidfog Technologies
  • ClorDiSys Solutions Inc.
  • Amira Srl Unipersonale
  • Noxilizer, Inc.

Strategic Development

  • On 11 October 2022, ChargePoint Technology Group, which is a powder as well as liquid transfer expert, and STERIS, a global leader of infection prevention and other procedural products manufacturing and services, have collaborated to give a successful sterile solution to specialty chemicals manufacturer Evonik.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/1460

Some Key Highlights From the Report

  • On 26 October 2022, Bio-One Sciences introduced a chemical-free, non-invasive UVC disinfection solution for medical device production cleanrooms. Their revolutionary service delivers a constant stream of UVC rays that quickly and effectively destroy the Deoxyribonucleic Acid (DNA) of germs and illnesses. This eco-friendly solution eliminates the guesswork and inefficiencies associated with manual washing and disinfection.
  • The equipment segment is expected to account for largest revenue share during the forecast period, which is attributed to increased preference for automated bio decontamination technologies over manual bio decontamination methods. In addition, faster patient flow in hospitals, less waste, ease of use, mobility, and a small footprint all contribute to revenue growth of the segment.
  • The chamber decontamination segment is expected to account for largest revenue share during the forecast period, which is attributed to its affordable cost and low power usage. Decontamination chambers are designed for usage in pharmaceutical, industrial, laboratory, or research environments. They provide a gas-tight compartment for quick and simple decontamination of equipment and items entering a clean facility, as well as routine decontamination within the facility. These aforementioned factors are expected to drive revenue growth of the segment.
  • The market in North America is expected to account for largest revenue share during the forecast period, which is attributed primarily to substantial investments in medical facilities, stringent patient safety regulations, and rising HAI rates in the region. HAIs, for example, is estimated to cause 1.7 million illnesses and 99,000 deaths in American hospitals alone every year by the Centers for Disease Control (CDC). Urinary tract infections are among these illnesses, accounting for 32% of all healthcare-acquired infections. Efficient bio decontamination services are thus required to aid in the prevention of nosocomial infection transmission, hence driving revenue growth of the market in the region.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/bio-decontamination-market

Emergen Research has segmented the global bio decontamination market on the basis of product & service, agent type, type, end-use, and region:

  • Product & Service Outlook (Revenue, USD Million; 2019–2030)
    • Equipment
    • Services
    • Consumables
  • Agent Type Outlook (Revenue, USD Million; 2019–2030)
    • Hydrogen Peroxide
    • Chlorine Dioxide
    • Peracetic Acid
    • Nitrogen Dioxide
  • Type Outlook (Revenue, USD Million; 2019–2030)
    • Chamber Decontamination
    • Room Decontamination
  • End-use Outlook (Revenue, USD Million; 2019–2030)
    • Pharmaceutical & Medical Device Manufacturing Companies
    • Life Sciences & Biotechnology Research Organizations
    • Hospitals & Healthcare Facilities
  • Regional Outlook (Revenue, USD Million; 2022-2030)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Sweden
      7. BENELUX
      8. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. U.A.E.
      3. South Africa
      4. Israel
      5. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Nebulizers Market, By Product (Ultrasonic Nebulizer, Jet Nebulizer, Mesh Nebulizer), By Modality (Table-Top, Portable), By End-User (Clinics, Hospitals, Homecare-Settings), and By Region Forecast to 2030

Disposable Urine Bag Market, By Material (Polyvinyl Chloride, Paper), By Product Type (Body-Worn Bag, Large Capacity Bag), By End-Use (Hospitals, Nursing Homes, Home Care), and By Region Forecast to 2030

Alagille Syndrome Market, By Diagnostic Method (Genetic testing, Liver biopsy, Heart and blood vessel tests, Others), By Treatment Type (Drug Medications and Surgery), By Treatment Centers (Hospitals, Diagnostic Centers and Others), By Region Forecast to 2030

Anticonvulsants Market, By Drug Type (AMPA, NMDAR, Carbamate Anticonvulsants, Barbiturate, Triazine), By Drug Generation (First Generation, Second Generation), By Distribution Channel (Online Pharmacies), and By Region Forecast to 2030

Lip Augmentation Market, By Type (Temporary, Permanent), By Product (Hyaluronic Acid Fillers, Fat Injection Or Lipoinjection, Poly-L-Lactic Acid Fillers, Lip Collagen, Others), and By Region Forecast to 2030

Synbiotics Market, By Form (Powdered, Liquid), By Application (Food & Beverages, Dairy, Pharmaceuticals, Aquaculture Farming), By Distribution Channel (Indirect, Direct), and By Region Forecast to 2030

Contract Research Organization Market, By Service Type (Clinical Research Services), By Application (Infectious Diseases, Immunological Disorders), By End-Use (Medical Device Companies, Biopharmaceutical Companies), and By Region Forecast to 2030

Microneedling Market, By Type (Laser, Radiofrequency, Rollers), By Needle Material (Metal, Glass, Silicon), By Application (Skin Rejuvenation, Alopecia) By End-Use (Hospitals, Dermatology Clinics), and By Region Forecast to 2030

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Bio Decontamination Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-bio-decontamination-market

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.